Fresenius SE & Co. KGaA Share Price Other OTC
Equities
FSNUY
US35804M1053
Healthcare Facilities & Services
Sales 2024 * | 22.19B 24.04B 1,890B | Sales 2025 * | 23.33B 25.28B 1,987B | Capitalization | 15.5B 16.8B 1,321B |
---|---|---|---|---|---|
Net income 2024 * | 1.41B 1.53B 120B | Net income 2025 * | 1.74B 1.88B 148B | EV / Sales 2024 * | 1.26 x |
Net Debt 2024 * | 12.44B 13.48B 1,059B | Net Debt 2025 * | 11.7B 12.68B 997B | EV / Sales 2025 * | 1.17 x |
P/E ratio 2024 * |
11.1
x | P/E ratio 2025 * |
8.81
x | Employees | - |
Yield 2024 * |
3.43% | Yield 2025 * |
3.78% | Free-Float | 73.04% |
Latest transcript on Fresenius SE & Co. KGaA
Managers | Title | Age | Since |
---|---|---|---|
Michael Sen
CEO | Chief Executive Officer | 55 | 11/04/21 |
Sara Hennicken
DFI | Director of Finance/CFO | 44 | 31/12/18 |
Michael Moser
CMP | Compliance Officer | - | 17/07/23 |
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Diekmann
BRD | Director/Board Member | 69 | 19/05/15 |
Wolfgang Kirsch
CHM | Chairman | 69 | 31/12/19 |
Konrad Kölbl
BRD | Director/Board Member | 64 | 15/07/07 |
1st Jan change | Capi. | |
---|---|---|
+18.63% | 84.11B | |
-27.41% | 71.96B | |
+1.97% | 27.25B | |
-9.66% | 17.31B | |
+3.96% | 15.92B | |
+7.75% | 13.68B | |
+72.83% | 13.29B | |
+72.50% | 12.73B | |
+32.39% | 12.16B |